시장보고서
상품코드
1632595

세계의 동물 심장병학 시장 - 규모, 점유율, 동향 분석 보고서 : 동물 유형별, 제품별, 적응증별, 최종 용도별, 유통 채널별, 지역별, 부문 예측(2025-2030년)

Veterinary Cardiology Market Size, Share & Trends Analysis Report By Animal Type (Companion, Production), By Product (Pharmaceuticals, Diagnostics), By Indication, By End-use, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

동물 심장병학 시장 규모와 동향 :

세계 동물 심장병학 시장 규모는 2024년에는 27억 9,000만 달러로 2025년부터 2030년까지 연평균 복합 성장률(CAGR) 8.41%를 나타낼 것으로 예측됩니다.

동반 동물, 특히 개 심장 질환의 유병률의 높이는 동물 심장 병학 분야의 중요한 시장 성장 촉진요인입니다. 질병으로 진단되며,이 숫자는 고령견에서 60% 이상으로 상승합니다.이 경우 중 점액종성 승모판막증(MMVD) 미국의 개 심장병 증례의 75%를 차지하며, 주로 심장판막에 영향을 미치고 있습니다. 이러한 질병의 광범위한 발생은 고급 진단, 치료 및 전문 동물 관리에 대한 수요 증가를 강조하고 시장 확대에 박차를 가하고 있습니다.

예를 들어, 2024년 6월 인도 농업 연구위원회는 2022년 7월부터 2023년 9월까지 14개월 동안 전신 질환의 병력이 있는 435마리의 심장 부정맥 발생률을 조사했습니다. 연구를 발표했습니다. 이 평가는 부정맥의 발생을 밝히는 것을 목적으로 한 것으로, 114마리(26.21%) 심방세동(30.70%), ST부문 코빙, 동정지(각 9.65%), ST부문 상승(각 8.77%) 등 다양한 유형이 인정되었습니다. 이것이 시장의 성장을 더욱 촉진하고 있습니다. Animal Review(LAR)의 연구에 따르면, CHD는 출생시 존재하는 심장 질환으로 소에서의 유병률은 0.2%에서 2.7%로 보고되었습니다.

또한, 예방 위생에 대한 의식이 높아짐에 따라 반려동물의 주인은 그들의 전반적인 행복을 향상시키기 위해 그들의 건강에 더 많은 비용을 소비하게되었습니다. 하는 지출 증가는 시장 성장의 현저한 촉진요인입니다. 이 상승 추세는 반려동물의 사육 수 증가, 반려동물의 건강에 대한 의식 증가, 동물 진단 및 치료의 진보를 반영합니다. 심장병학 서비스를 포함한 전문적인 케어를 점점 우선시하고 있으며, 이 지출의 급증은 혁신적인 솔루션과 동물 심장병 서비스의 확대에 대한 수요를 지원하고 있습니다.

반려동물이 직면 할 수있는 심장 질환을 포함한 다양한 질병에 사용할 수있는 다양한 치료 옵션에 대한 동물 의약품의 발전과 지식 증가는 시장 성장을 뒷받침합니다. 향상 프로그램은 반려동물 주인이 이러한 치료 옵션을 검토할 수 있도록 합니다. VIS 2023은 획기적인 행사가 될 것으로 예상되며, 동물 의료에서 혁신과 진보를 추진하기 위해 참가자를 고무시킬 가능성이 높습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 동물 심장병학 시장의 변동 동향과 범위

  • 시장 계통 전망
    • 상위 시장
    • 보조 시장
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
    • 시장 기회 분석
    • 시장 과제 분석
  • 동물 심장병학 시장 분석 툴
    • 업계 분석 - Porter's Five Forces 분석
    • PESTEL 분석
    • 규제 프레임워크
    • 가격 분석
    • 동물의 추정 개체수 : 주요 국가별·주요종별, 2024년
    • COVID-19의 영향 분석

제4장 동물 심장병학 시장 : 동물 유형 추정·동향 분석

  • 부문 대시보드
  • 동물 심장병학 시장 :동물 유형 변동 분석
  • 동물 심장병학 시장 규모와 동향 분석, 동물 유형별, 2018-2030년
  • 반려동물
    • 고양이
    • 기타
  • 생산동물
    • 가금
    • 기타

제5장 동물 심장병학 시장 : 제품별 추정·동향 분석

  • 부문 대시보드
  • 동물 심장병학 시장 : 제품 변동 분석
  • 동물 심장병학 시장 규모와 동향 분석, 제품별, 2018-2030년
  • 의약품
    • 피모벤단
    • 스피로노락톤·염산베나제프릴
    • 기타
  • 진단
    • 신체 검사
    • 흉부 X선 검사
    • 심전도(ECG)
    • 기타

제6장 동물 심장병학 시장 :적응증별 추정·동향 분석

  • 부문 대시보드
  • 동물 심장병학 시장 :적응증별 변동 분석
  • 동물 심장병학 시장 규모와 동향 분석, 적응증별, 2018-2030년
    • 울혈성 심부전
    • 심근 질환
    • 부정맥
    • 기타

제7장 동물 심장병학 시장 : 최종 용도별 추정·동향 분석

  • 부문 대시보드
  • 동물 심장병학 시장 : 최종 용도 변동 분석
  • 동물 심장병학 시장 규모와 동향 분석, 최종 용도별, 2018-2030년
    • 동물병원 및 클리닉
    • 기타

제8장 동물 심장병학 시장 : 유통 채널별 추정·동향 분석

  • 부문 대시보드
  • 동물 심장병학 시장 : 유통 채널별 변동 분석
  • 동물 심장병학 시장 규모와 동향 분석, 유통 채널별, 2018-2030년
    • 병원 및 클리닉 약국
    • 소매
    • 전자상거래

제9장 동물 심장병학 시장 :지역 추정·동향 분석

  • 지역 대시보드
  • 동물 심장병학 시장 점유율, 지역별, 2024년·2030년, 백만 달러
  • 지역 전망
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 호주
    • 한국
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제10장 경쟁 구도

  • 시장 진출기업의 분류
  • 기업 시장 포지셔닝 분석/힙 맵 분석
  • 기업 프로파일
    • Boehringer Ingelheim International GmbH
    • Jurox Pty Limited
    • Ceva
    • Merck &Co., Inc.
    • IDEXX
    • Apex Bio Medical
    • SOUND
    • General Electric Company
    • FUJIFILM Holdings America Corporation
    • ESAOTE SPA
  • 기타 주요 기업 목록
JHS 25.01.31

Veterinary Cardiology Market Size & Trends:

The global veterinary cardiology market size was valued at USD 2.79 billion in 2024 and is projected to grow at a CAGR of 8.41% from 2025 to 2030. The high prevalence of cardiologic disorders among companion animals, particularly dogs, is a significant market driver for the veterinary cardiology sector. Research indicates that approximately 10% of all dogs seen in primary care animal settings are diagnosed with heart disease, with this figure rising to over 60% in older dogs. Among these cases, myxomatous mitral valve disease (MMVD) stands out, accounting for 75% of canine heart disease cases in the U.S., primarily affecting heart valves. Another critical condition, dilated cardiomyopathy (DCM), directly impacts the heart muscle. The widespread occurrence of these disorders underscores the growing demand for advanced diagnostics, therapeutics, and specialized animal care, fueling the expansion of the market.

For instance, in June 2024, the Indian Council for Agricultural Research published a study examining the incidence of cardiac arrhythmias in 435 dogs with a history of generalized diseases over 14 months from July 2022 to September 2023. The assessment was aimed to determine the occurrence of arrhythmias and found that 114 dogs (26.21%) displayed various types, including atrial fibrillation (30.70%), ST-segment coving, sinus arrest (9.65% each), and ST-segment elevation (8.77% each). Moreover, there is a rising prevalence of CHD among cattle which is further driving the market growth. For instance, according to the Large Animal Review (LAR) study published in June 2023, CHD is a heart condition that is present at birth, with a reported prevalence ranging from 0.2% to 2.7% in cattle.

Moreover, the increasing awareness regarding preventive health has led pet owners to spend more on their health to improve their overall well-being. The rising expenditure on animal care is a notable driver for the growth of the market. According to the article published in February 2024, the Bureau of Labor Statistics found that the cost of veterinary services increased by 7.5% from September 2022 to September 2023. This upward trend reflects growing pet ownership, heightened awareness of pet health, and advancements in veterinary diagnostics and treatments. As pet owners increasingly prioritize specialized care, including cardiology services, this surge in spending supports the demand for innovative solutions and expanded animal cardiology offerings.

The growing advancements in animal medications and knowledge about various treatment options available for different disorders, including heart diseases that pets may face, are propelling the market growth. Pet health awareness programs enable pet owners to explore these treatment options. For instance, in June 2023, the Veterinary Innovation Summit (VIS) was organized to bring together professionals, innovators, and thought leaders in the field of animal health care to discuss and shape the future of veterinary medicine. VIS 2023 is expected to be a groundbreaking event that is likely to inspire attendees to drive innovation and advancements in animal health care.

Global Veterinary Cardiology Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global veterinary cardiology market report on the basis of animal type, product, indication, end use, distribution channel, and region:

  • Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Others
  • Production Animals
    • Cattle
    • Poultry
    • Others
  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceuticals
    • Pimobendan
    • Spironolactone and benazepril hydrochloride
    • Others
  • Diagnostics
    • Physical exam
    • Chest X-rays
    • Electrocardiogram (ECG)
    • Others
  • Indication Outlook (Revenue, USD Million, 2018 - 2030)
  • Congestive Heart Failure
  • Myocardial (Heart Muscle) Disease
  • Arrhythmias
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Veterinary Hospitals & Clinics
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital/ Clinic Pharmacy
  • Retail
  • E-Commerce
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Sweden
    • Denmark
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Rest of MEA

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Cardiology Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Prevalence Of Chronic Diseases In Animals
      • 3.2.1.2. Increasing Animal Health Expenditure
      • 3.2.1.3. Rising Surgical Procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulations
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Cardiology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Pricing Analysis
    • 3.3.5. Estimated Animal Population, by key countries & Key species, 2024
    • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Veterinary Cardiology Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Cardiology Market: Animal type Movement Analysis
  • 4.3. Veterinary Cardiology Market Size & Trend Analysis, by Animal Type, 2018 to 2030 (USD Million)
  • 4.4. Companion Animals
    • 4.4.1. Companion Animals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Dogs
      • 4.4.2.1. Dogs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Cats
      • 4.4.3.1. Cats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Horses
      • 4.4.4.1. Horses Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Production Animals
    • 4.5.1. Production Animals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Cattle
      • 4.5.2.1. Cattle Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Poultry
      • 4.5.3.1. Poultry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Cardiology Market: By Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Cardiology Market: By Product Movement Analysis
  • 5.3. Veterinary Cardiology Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Pharmaceuticals
    • 5.4.1. Pharmaceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Pimobendan
      • 5.4.2.1. Pimobendan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Spironolactone and Benazepril Hydrochloride
      • 5.4.3.1. Spironolactone and Benazepril Hydrochloride Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Diagnostics
    • 5.5.1. Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Physical exam
      • 5.5.2.1. Physical Exam Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Chest X-rays
      • 5.5.3.1. Chest X-rays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. Electrocardiogram (ECG)
      • 5.5.4.1. Electrocardiogram (ECG) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Others
      • 5.5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Cardiology Market: By Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Cardiology Market: By Indication Movement Analysis
  • 6.3. Veterinary Cardiology Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
    • 6.3.1. Congestive Heart Failure
      • 6.3.1.1. Congestive Heart Failure Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Myocardial (Heart Muscle) Disease
      • 6.3.2.1. Myocardial (Heart Muscle) Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Arrhythmias
      • 6.3.3.1. Arrhythmias Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Others
      • 6.3.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Cardiology Market: By End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary Cardiology Market: By End Use Movement Analysis
  • 7.3. Veterinary Cardiology Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
    • 7.3.1. Veterinary Hospitals & Clinics
      • 7.3.1.1. Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. Others
      • 7.3.2.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Cardiology Market: By Distribution Channel Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Veterinary Cardiology Market: By Distribution Channel Movement Analysis
  • 8.3. Veterinary Cardiology Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
    • 8.3.1. Hospital/ Clinic Pharmacy
      • 8.3.1.1. Hospital/ Clinic Pharmacy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. Retail
      • 8.3.2.1. Retail Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. E-Commerce
      • 8.3.3.1. E-Commerce Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Veterinary Cardiology Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Veterinary Cardiology Market Share, By Region, 2024 & 2030, USD Million
  • 9.3. Regional Outlook
  • 9.4. North America
    • 9.4.1. North America Veterinary Cardiology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. U.S. Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Canada Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Mexico Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. UK Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Germany Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. France Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Italy Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Spain Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. Denmark
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Denmark Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Sweden Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.9. Norway
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Norway Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Japan Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. China Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. India Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Australia Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. South Korea Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key Country Dynamics
      • 9.6.7.2. Thailand Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Brazil Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Argentina Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8. Middle East & Africa
    • 9.8.1. Middle East & Africa Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. South Africa Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Saudi Arabia Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. UAE Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Kuwait Veterinary Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Company Market Position Analysis/ Heap Map Analysis
  • 10.3. Company Profiles
    • 10.3.1. Boehringer Ingelheim International GmbH
      • 10.3.1.1. Company overview
      • 10.3.1.2. Financial performance
      • 10.3.1.3. Product benchmarking
      • 10.3.1.4. Strategic initiatives
    • 10.3.2. Jurox Pty Limited
      • 10.3.2.1. Company overview
      • 10.3.2.2. Financial performance
      • 10.3.2.3. Product benchmarking
      • 10.3.2.4. Strategic initiatives
    • 10.3.3. Ceva
      • 10.3.3.1. Company overview
      • 10.3.3.2. Financial performance
      • 10.3.3.3. Product benchmarking
      • 10.3.3.4. Strategic initiatives
    • 10.3.4. Merck & Co., Inc.
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. IDEXX
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Apex Bio Medical
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. SOUND
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. General Electric Company
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. FUJIFILM Holdings America Corporation
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. ESAOTE SPA
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
  • 10.4. List of other Key players
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제